Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...
The blood of a sickle cell patient under a light microscope. The sickling of the otherwise round red blood cells is clearly visible. Sickle cell anemia is the world’s most common genetic disorder. It ...
The U.S. Food and Drug Administration (FDA) on Tuesday approved Agios Pharmaceuticals, Inc.’s (NASDAQ: AGIO) Aqvesme (mitapivat), an oral pyruvate kinase (PK) activator, for anemia in adults with ...
Nine pharmaceutical companies have agreed to slash prices on their flagship drugs for Medicaid recipients and people who buy the medications in cash, rather than through insurance, as part of a new ...
STOCKHOLM, Dec. 8, 2025 /PRNewswire/ --BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi® (lecanemab), has been included in the "Commercial Insurance ...
Over 11,000 bottles of a high blood pressure medication have been recalled for potential cross contamination with another drug. Glenmark Pharmaceuticals Inc., based in New Jersey, has voluntarily ...
John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Elaine Chen covers biotech, ...
The federal government has announced the results of the latest round of Medicare drug price negotiations: 15 lower drug prices for Medicare to go into effect in 2027. Medicare will get a 71% discount ...
These cuts, amounting to a net savings of $12 billion from last year's Medicare spending, come as the cost of prescription medications remains a significant concern for millions of Americans, ...
The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which would have reduced its spending on those drugs by 44 percent. By Rebecca ...
A wave of vital prescription drugs is about to get a lot cheaper for people on Medicare. The Trump administration announced Tuesday that it has successfully negotiated lower prices for 15 drugs, ...
Amber is the Associate Editorial Director overseeing news content for Health, ensuring that readers stay up-to-date on trending topics like COVID-19, as well as the most recent research in the health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results